Six new networks were selected following a labeling campaign launched in July 2024 and the evaluation of the dossiers of 17 candidate networks. This evaluation was carried out by the F-CRIN Scientific Council, chaired by Pr Cristina Sampaïo and co-chaired by Pr Christian Ohmann. The deliberations were then submitted to the Governance Board, which brings together representatives from hospitals, academia, industry and patient associations, who ratified the labeling of these seven new networks.
Thanks to the F-CRIN label, these new networks will be able to draw on the full scientific, operational and collaborative power of the infrastructure, and benefit from:
- Funding for human resources and operating costs;
- The provision of operational tools (steering tools, shared databases, active patient files, validated procedures, ...) ;
- Targeted training in clinical research on themes of major importance to biomedical research ;
- Information and communication tools (brochures, website, events, press relations) ;
- Administrative, financial and legal support ;
- European visibility thanks to direct access to the European ECRIN infrastructure, for the extension to Europe of French-coordinated clinical projects, and the participation of French teams in multinational studies;
- And above all, the collective intelligence, feedback and dynamics of the F-CRIN network.
In total, since its inception, F-CRIN has participated in over 800 clinical research projects, 41% of which were international in scope, and initiated over 2,500 scientific publications. The national coordination and the various components benefit from the support of several university hospitals, universities, foundations and industrial partners.
For further information: Network CONDOR